Literature DB >> 30506330

Intratumoral HER2 heterogeneity in early gastric carcinomas: potential bias in therapeutic management.

Antonio Ieni1, Roberta Cardia2, Maria Lentini2, Giovanni Tuccari2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30506330     DOI： 10.1007/s00428-018-2502-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  5 in total

1.  Association of HER2 gene amplification and tumor progression in early gastric cancer.

Authors:  Kazuki Kanayama; Hiroshi Imai; Eri Usugi; Taizo Shiraishi; Yoshifumi S Hirokawa; Masatoshi Watanabe
Journal:  Virchows Arch       Date:  2018-08-17       Impact factor: 4.064

Review 2.  HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice.

Authors:  Federica Grillo; Matteo Fassan; Francesca Sarocchi; Roberto Fiocca; Luca Mastracci
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

3.  HER2/neu over-expression predicts poor outcome in early gastric cancer without lymph node metastasis.

Authors:  Yongjia Yan; Li Lu; Chunna Liu; Weidong Li; Tong Liu; Weihua Fu
Journal:  Clin Res Hepatol Gastroenterol       Date:  2014-08-28       Impact factor: 2.947

4.  Discordance rate of HER2 status in primary gastric carcinomas and synchronous lymph node metastases: a multicenter retrospective analysis.

Authors:  Antonio Ieni; Valeria Barresi; Rosario Caltabiano; Alessia Caleo; Luca Reggiani Bonetti; Salvatore Lanzafame; Pio Zeppa; Rosario Alberto Caruso; Giovanni Tuccari
Journal:  Int J Mol Sci       Date:  2014-12-03       Impact factor: 5.923

Review 5.  HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach.

Authors:  A Ieni; V Barresi; L Rigoli; R A Caruso; G Tuccari
Journal:  Dis Markers       Date:  2015-10-01       Impact factor: 3.434
  5 in total
  2 in total

1.  Significance of tumor heterogeneity of p-Smad2 and c-Met in HER2-positive gastric carcinoma with lymph node metastasis.

Authors:  Gen Tsujio; Koji Maruo; Yurie Yamamoto; Tomohiro Sera; Atsushi Sugimoto; Hiroaki Kasashima; Yuichiro Miki; Mami Yoshii; Tatsuro Tamura; Takahiro Toyokawa; Hiroaki Tanaka; Kazuya Muguruma; Masaichi Ohira; Masakazu Yashiro
Journal:  BMC Cancer       Date:  2022-06-01       Impact factor: 4.638

2.  Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer-Results from the AGMT GASTRIC-5 Registry.

Authors:  Florian Huemer; Lukas Weiss; Peter Regitnig; Thomas Winder; Bernd Hartmann; Josef Thaler; Gudrun Piringer; Clemens A Schmitt; Wolfgang Eisterer; Hannes Gänzer; Alois Wüstner; Johannes Andel; Björn Jagdt; Hanno Ulmer; Richard Greil; Ewald Wöll
Journal:  J Clin Med       Date:  2020-03-29       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.